Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Cycloheptanone" patented technology

Cycloheptanone, (CH₂)₆CO, is a cyclic ketone also referred to as suberone. It is a colourless volatile liquid. Cycloheptanone is used as a precursor for the synthesis of pharmaceuticals.

Pyrrolidone, piperidone and azetidinone terminated and functionalizes dendritic polymers

Heterocycle terminated dendritic polymers. More specifically, the production of 2-pyrrolidone, 2-piperidone, 2-aza-cycloheptanone or 2-azetidinone-terminated dendritic polymers obtained by reacting precursor primary amine,(e.g., —NH2)-terminated dendritic polymers with certain functionalized methacrylate reagents to produce new and novel dendritic polymers terminated with ester substituted 2-pyrrolidone, 2-piperidone, 2-aza-cycloheptanone or 2-azetidinone groups.
Owner:DENDRITIC NANO TECH INC

Chiral N-heterocyclic carbene catalyst as well as preparation method and application thereof

The invention discloses a chiral N-heterocyclic carbene catalyst as well as a preparation method and application thereof, and belongs to the technical field of organic chemistry. The preparation method of the chiral N-heterocyclic carbene catalyst specifically comprises the following steps: adding N-bromo-succinimide and p-toluenesulfonic acid into a round-bottom flask, dissolving the N-bromo-succinimide and p-toluenesulfonic acid with DCM, adding 1eq of cycloheptanone 1, and reacting at room temperature overnight; after the reaction is completed, concentrating and purifying the reactant to obtain alpha-bromo-cycloheptanone 2; then weighing 1g of montmorillonite, 10mmol of p-methylaniline and 40mmol of phenylacetylene, carrying out solvent-free reaction at 140 DEG C for 8 hours, cooling the reaction product to room temperature, filtering the reaction product, washing the reaction product with diethyl ether, collecting filtrate, concentrating and purifying the filtrate to obtain a compound 5, carrying out asymmetric hydrogenation reduction on the compound 5, and carrying out multi-step reaction on the compound 5 and alpha-bromo-cycloheptanone 2 to synthesize a target compound 7. The method is high in operability, novel in synthetic route and high in yield. The method can be successfully applied to the amide far-end C (sp3)-H activation tandem cyclization reaction, realizes asymmetric catalysis, and has a wide market application prospect.
Owner:CHENGDU UNIV

Method for synthesizing flea beetle aggregation pheromone

The invention belongs to the technical field of green pesticides, and discloses a novel method for synthesizing flea beetle aggregation pheromone. The method comprises the following steps of: with cycloheptanone (2) taken as an initial raw material, carrying out bromination reaction on the cycloheptanone and NBS (N-bromosuccinimide), carrying out elimination reaction under the alkaline condition of lithium bromide and lithium carbonate to obtain cycloheptenone 3, carrying out asymmetric Michael addition reaction under the catalysis of copper to prepare chiral methyl cycloheptanone 4; and making the chiral methyl cycloheptanone 4 react with methyl iodide to obtain trimethyl cycloheptanone 5. carrying out aldol condensation reaction on the trimethyl cycloheptanone 5 and trimethylsilyl ketene under the catalysis of LDA to prepare diketone 6; and finally carrying out Robinson cyclization reaction to obtain flea beetle aggregation pheromone 1. The asymmetric Michael addition reaction is utilized for the first time to construct the chiral methyl of the flea beetle aggregation pheromone, and the method has the advantages of being simple in synthetic route, easy to operate and the like.
Owner:CHINA AGRI UNIV

Synthesis method of intermediate cycloheptanone of guanethidine sulfate drug

A synthesis method of intermediate cycloheptanone of a guanethidine sulfate drug comprises the steps as follows: (i) 500-600 ml of water, 1.5 mol of metal powder and a phosphoric acid solution with the mass percentage being 40% -50% are added to a reaction vessel equipped with a stirrer, a thermometer and a dropping funnel, the temperature of the solution is controlled to be 60-70 DEG C, 1.2 mol of nitromethylcyclohexanol is added dropwise, the temperature of the solution is maintained to be 40-50 DEG C after addition, 30 mL of a sulfuric acid solution with the mass percentage being 40%-45% is added at an interval of 30 min and is added 3 times altogether, the pH of the solution is maintained to be 3-4 for 1 h, the filtrate is an aminomethyl cyclohexanol sulfate solution, and the filter cake is washed with a solvent and used for the next batch; (ii) pH of the solution is adjusted with sulfuric acid to be 2-3, the solution temperature is reduced to 2-5 DEG C, 1.5-2 mol of a sodium sulfite solution is added slowly and dissolved in 200 ml of water, the temperature is increased to 30-35 DEG C, distillation is performed through steam until no oily substances are distilled off, an oil layer is separated, a water layer is extracted with a solvent for 10-15 times, the oil layer and the solvent layer are combined, a solvent is distilled off under atmospheric pressure, distilling under reduced pressure is performed, a fraction at 65-70 DEG C is collected, and cycloheptanone is obtained.
Owner:厦门莱恩斯特信息科技有限公司

Preparation method of 2-diethylamino-1-methylethyl-7-cyclohexyl-7-oxoheptanoate

The invention provides a compound 2-diethylamino-1-methylethyl-7-cyclohexyl-7-oxo-heptanoate (1) and a synthesis method thereof. The compound 1 adopts a structural formula as shown in the specification. The invention further provides the application of the compound 1 as an impurity reference substance for monitoring synthesis of an active pharmaceutical ingredient of rociverine. By taking cycloheptanone as a starting material, the compound 1 is synthesized through a four-step reaction; the obtained product is simple in posttreatment of each step, the product is convenient and easy to obtain, the compound 1 is suitable for being synthesized on a large scale, and a relevant substance or the impurity reference substance are provided for quality research on the synthesis of the active pharmaceutical ingredient of the rociverine.
Owner:SHANGHAI INST OF PHARMA IND +1

Synthetic method of guanethidine subplate drug intermediate cycloheptanone

The invention provides a synthetic method of guanethidine subplate drug intermediate cycloheptanone. The synthetic method comprises the following steps: (1) adding 500 to 600ml of water, 1.5mol of metal powder, a phosphoric acid solution with the mass fraction of 40 to 50 percent into a reaction vessel provided with a stirrer, a thermometer and a dropping funnel, wherein the solution temperature is controlled to be 60 to 70 DEG C, dropwise adding 1.2mol of nitromethylcycloheanol, after adding, maintaining the solution temperature at 40 to 50 DEG C, adding 30mL of sulfuric acid solution with the mass fraction of 40 to 45 percent for 3 times every 30min, and maintaining the solution pH at 3 to 4 for 1h, wherein filter liquor is aminomethlcycloheanol sulfate liquor, and a filter liquor cake is used for the next batch after being washed by using a solvent; (2) regulating the solution pH to 2 to 3 by using sulfuric acid, reducing the solution temperature to 2 to 5 DEG C, slowly adding and dissolving 1.5 to 2mol of sodium sulfite in 200ml of water, then heating up to 30 to 35 DEG C, distilling by using steam till a non-oily matter is distilled off, separating out an oil layer, extracting a water layer for 10 to 15 times by a solvent, combining the oil layer and a solvent layer, distilling off the solvent at normal pressure, then performing reduced pressure distillation, and collecting 65 to 70 DEG C cut fraction to obtain the cycloheptanone.
Owner:CHENGDU ZHONGHENG HUATIE TECH CO LTD

Camphor-based ketoxime fluorescent probe for detecting hypochlorous acid as well as preparation method and application of camphor-based ketoxime fluorescent probe

PendingCN114478308ADetection of hypochlorous acid contentGood choiceOximes preparationFluorescence/phosphorescenceFluoProbesHydroxylamine
The invention discloses a camphor-based ketoxime fluorescent probe for detecting hypochlorous acid as well as a preparation method and application of the camphor-based ketoxime fluorescent probe. The fluorescent probe is 3-(9-anthracene methylene)-1, 7, 7-trimethyl bicyclo [2.2. 1] heptyl-2-ketoxime, and the structural formula of the fluorescent probe is shown in the description. According to the invention, 3-(9-anthracene methylene)-1, 7, 7-trimethyl bicyclo [2.2. 1] heptyl-2-ketone is used as a raw material, and the 3-(9-anthracene methylene)-1, 7, 7-trimethyl bicyclo [2.2. 1] heptyl-2-ketoxime is obtained by carrying out condensation reaction on the 3-(9-anthracene methylene)-1, 7, 7-trimethyl bicyclo [2.2. 1] heptyl-2-ketone and hydroxylamine hydrochloride. The compound can selectively react with hypochlorous acid, and the fluorescence color of a probe solution is changed from colorless to bright blue under the irradiation of 365nm ultraviolet light, so that the compound can be used as a fluorescent probe for selectively detecting hypochlorous acid, the probe can quickly and sensitively detect the content of hypochlorous acid in the solution, the detection range is 0-180 mu M, and the application prospect is broad. The detection limit is as low as 1.18 * 10 <-7 > M, the detection time is less than 5 s, and the method has a good application prospect.
Owner:NANJING FORESTRY UNIV

Compound for inhibiting the growth and proliferation of human liver cancer cells and method for synthesizing it

The compound “2-((4-nitrophenyl)amino)-6,7,8,9-tetrahydro-3H-cyclohepta[4,5]thieno-[2,3-d]pyrimidin-4(5H)-one” and method of synthesizing it, wherein the compound is effective to inhibit the growth and proliferation of human liver cancer cells HepG2. The compound has an inhibitory concentration value (IC50) of 0.7 μg, compared to reference medication Doxorubicin that has an (IC50) value of 1.2 μg. It further surpasses that reference medication Doxorubicin at all tested concentraions. The method includes the steps of: preparing a first compound of cycloheptanone, ethylcyanoacetate, sulfur, ethanol and diethyl amine; preparing a second compound by heating of the first compound with excess of hydrazine hydrate in absolute ethanol as solvent; and preparing the effective compound of the invention by reaction of the second chemical compound with 4-nitrophenylisothiocyanate in dry dimethylformamide as solvent.
Owner:ALGHAMDI ZAINAB SAEED
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products